Crocetta Argento

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Medicine, Hematology, Pharmacology +6

Long‐term sequential deferiprone–deferoxamine <i>versus</i> deferiprone alone for thalassaemia major patients: a randomized clinical trial

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · British Journal of Haematology · 2009 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +14

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Medicine, Hematology, Internal Medicine +12

Bone demineralization in adult thalassaemic patients: contribution of GH and IGF‐I at different skeletal sites

Massimo Scacchi, Leila Danesi, Agnese Cattaneo et al. · Clinical Endocrinology · 2008 · 43 citations

Medicine, Endocrinology, Bone Metabolism +16

Growth hormone deficiency (GHD) in adult thalassaemic patients

Massimo Scacchi, Leila Danesi, Agnese Cattaneo et al. · Clinical Endocrinology · 2007 · 37 citations

Medicine, Endocrinology, Pediatrics +13